Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfatc1
|
ENSMUSG00000033016.9 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_80608966_80609299 | Nfatc1 | 157 | 0.950796 | 0.84 | 8.4e-16 | Click! |
chr18_80640288_80640565 | Nfatc1 | 31451 | 0.145274 | 0.79 | 7.4e-13 | Click! |
chr18_80631263_80631965 | Nfatc1 | 22639 | 0.162480 | 0.75 | 5.1e-11 | Click! |
chr18_80631992_80632183 | Nfatc1 | 23112 | 0.161626 | 0.71 | 1.3e-09 | Click! |
chr18_80617436_80617605 | Nfatc1 | 8545 | 0.186329 | 0.70 | 2.1e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_170605499_170605914 | 15.89 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
15845 |
0.17 |
chr2_152636359_152637068 | 15.86 |
Rem1 |
rad and gem related GTP binding protein 1 |
3746 |
0.1 |
chr15_38950893_38951406 | 13.88 |
Gm49097 |
predicted gene, 49097 |
12527 |
0.14 |
chr15_53370344_53370653 | 13.28 |
Gm27926 |
predicted gene, 27926 |
13421 |
0.24 |
chr10_83805128_83805750 | 11.80 |
Gm47245 |
predicted gene, 47245 |
6126 |
0.26 |
chr18_51239889_51240171 | 11.52 |
Gm25739 |
predicted gene, 25739 |
14245 |
0.3 |
chr17_26861440_26861764 | 10.95 |
Gm20468 |
predicted gene 20468 |
181 |
0.9 |
chr14_62144524_62144913 | 10.90 |
Gm35419 |
predicted gene, 35419 |
26408 |
0.2 |
chr14_57035004_57035538 | 10.75 |
B020004C17Rik |
RIKEN cDNA B020004C17 gene |
20137 |
0.15 |
chr6_51334061_51334392 | 10.67 |
Gm6559 |
predicted gene 6559 |
45484 |
0.12 |
chr10_76642712_76643426 | 10.48 |
Col6a2 |
collagen, type VI, alpha 2 |
19439 |
0.14 |
chr12_79488971_79489164 | 10.06 |
Rad51b |
RAD51 paralog B |
161714 |
0.03 |
chr16_37732397_37732723 | 10.05 |
Gm4600 |
predicted gene 4600 |
35220 |
0.14 |
chr6_117134651_117134802 | 9.99 |
Gm43930 |
predicted gene, 43930 |
9599 |
0.19 |
chr4_82065654_82065945 | 9.72 |
Gm5860 |
predicted gene 5860 |
74 |
0.52 |
chr1_81725077_81725242 | 9.46 |
Gm5530 |
predicted gene 5530 |
17810 |
0.26 |
chr8_13699669_13699837 | 9.34 |
Cfap97d2 |
CFAP97 domain containing 2 |
6136 |
0.17 |
chr10_93335878_93336097 | 8.99 |
Gm17745 |
predicted gene, 17745 |
594 |
0.71 |
chr11_68638282_68638626 | 8.85 |
Ccdc42 |
coiled-coil domain containing 42 |
44399 |
0.11 |
chr5_31644975_31645128 | 8.85 |
Rbks |
ribokinase |
4513 |
0.13 |
chr18_10787909_10788064 | 8.78 |
Mir133a-1hg |
Mir133a-1, Mir1b and Mir1a-2 host gene |
2103 |
0.17 |
chr13_78483534_78483760 | 8.65 |
Gm32067 |
predicted gene, 32067 |
293 |
0.93 |
chr10_58416598_58416943 | 8.44 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
127 |
0.97 |
chr10_94824240_94824410 | 8.37 |
Gm24186 |
predicted gene, 24186 |
2670 |
0.23 |
chr2_152653004_152653244 | 8.30 |
1700030C14Rik |
RIKEN cDNA 1700030C14 gene |
1206 |
0.27 |
chr6_36541325_36541636 | 8.23 |
Gm43441 |
predicted gene 43441 |
46297 |
0.16 |
chr10_120914717_120915223 | 8.20 |
Gm16166 |
predicted gene 16166 |
13216 |
0.13 |
chr15_41869602_41869995 | 8.18 |
Abra |
actin-binding Rho activating protein |
78 |
0.97 |
chr2_61045573_61045766 | 8.18 |
Gm13579 |
predicted gene 13579 |
14699 |
0.25 |
chr16_92443664_92444018 | 8.02 |
Gm46555 |
predicted gene, 46555 |
13636 |
0.13 |
chr18_80608966_80609299 | 7.95 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
157 |
0.95 |
chr5_30556400_30556600 | 7.93 |
Cib4 |
calcium and integrin binding family member 4 |
10664 |
0.12 |
chr7_83443549_83443913 | 7.85 |
Gm44991 |
predicted gene 44991 |
27977 |
0.15 |
chr8_104609315_104609657 | 7.84 |
Cdh16 |
cadherin 16 |
3778 |
0.11 |
chr11_59364025_59364376 | 7.75 |
Gm15755 |
predicted gene 15755 |
11261 |
0.12 |
chr8_104606382_104606800 | 7.72 |
Cdh16 |
cadherin 16 |
6673 |
0.1 |
chr18_8644320_8645204 | 7.66 |
Gm35232 |
predicted gene, 35232 |
34289 |
0.18 |
chr17_80825502_80826283 | 7.63 |
C230072F16Rik |
RIKEN cDNA C230072F16 gene |
70901 |
0.1 |
chr10_93297846_93298129 | 7.60 |
Elk3 |
ELK3, member of ETS oncogene family |
12824 |
0.16 |
chr3_37128257_37128628 | 7.59 |
Il2 |
interleukin 2 |
2483 |
0.19 |
chr14_26690831_26690982 | 7.53 |
Dnah12 |
dynein, axonemal, heavy chain 12 |
2368 |
0.21 |
chrX_42398787_42399138 | 7.50 |
Gm14619 |
predicted gene 14619 |
51450 |
0.15 |
chr4_62732780_62733235 | 7.50 |
Gm11211 |
predicted gene 11211 |
5470 |
0.19 |
chr13_12369982_12370308 | 7.47 |
Gm5445 |
predicted gene 5445 |
8013 |
0.16 |
chr9_63896391_63896836 | 7.39 |
Gm18541 |
predicted gene, 18541 |
1652 |
0.39 |
chr4_97974171_97974322 | 7.39 |
Nfia |
nuclear factor I/A |
63213 |
0.14 |
chr11_101830206_101830433 | 7.33 |
Etv4 |
ets variant 4 |
44948 |
0.09 |
chr10_57040297_57040501 | 7.22 |
Gm36827 |
predicted gene, 36827 |
58167 |
0.13 |
chr15_93525280_93525546 | 7.17 |
Prickle1 |
prickle planar cell polarity protein 1 |
5890 |
0.28 |
chr2_170365296_170365488 | 7.14 |
Bcas1 |
breast carcinoma amplified sequence 1 |
8279 |
0.18 |
chr6_143558370_143558536 | 7.12 |
4930579D09Rik |
RIKEN cDNA 4930579D09 gene |
22945 |
0.24 |
chr1_193317140_193317601 | 7.11 |
Lamb3 |
laminin, beta 3 |
3325 |
0.16 |
chr2_163353818_163354318 | 7.10 |
Tox2 |
TOX high mobility group box family member 2 |
33690 |
0.12 |
chr18_13620932_13621256 | 7.03 |
AC103362.1 |
novel transcript |
19694 |
0.28 |
chr11_102648023_102648261 | 7.00 |
Gm22920 |
predicted gene, 22920 |
11538 |
0.09 |
chr19_31065463_31065614 | 6.97 |
Cstf2t |
cleavage stimulation factor, 3' pre-RNA subunit 2, tau |
17299 |
0.26 |
chr2_27939528_27939733 | 6.95 |
2810430I11Rik |
RIKEN cDNA 2810430I11 gene |
52578 |
0.12 |
chr3_98410923_98411117 | 6.95 |
Zfp697 |
zinc finger protein 697 |
28472 |
0.12 |
chr3_97076076_97076280 | 6.95 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16607 |
0.15 |
chr14_54966795_54967354 | 6.92 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
147 |
0.84 |
chr7_109191268_109192295 | 6.92 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr1_162938415_162938748 | 6.91 |
Fmo6 |
flavin containing monooxygenase 6 |
1066 |
0.49 |
chr9_46196948_46197278 | 6.91 |
Sik3 |
SIK family kinase 3 |
22458 |
0.1 |
chr10_3696761_3696912 | 6.90 |
Plekhg1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
43528 |
0.18 |
chr8_89993734_89993908 | 6.90 |
Gm24212 |
predicted gene, 24212 |
326517 |
0.01 |
chr14_29017877_29018134 | 6.88 |
Lrtm1 |
leucine-rich repeats and transmembrane domains 1 |
203 |
0.94 |
chr13_73298707_73299132 | 6.86 |
Gm10263 |
predicted gene 10263 |
18925 |
0.13 |
chr4_147335450_147336299 | 6.85 |
Zfp988 |
zinc finger protein 988 |
3467 |
0.17 |
chr9_106348383_106348776 | 6.83 |
Gm29123 |
predicted gene 29123 |
12746 |
0.12 |
chr12_8847341_8847509 | 6.82 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
29957 |
0.15 |
chr13_37602443_37602615 | 6.80 |
Gm47753 |
predicted gene, 47753 |
20258 |
0.1 |
chr16_44632721_44633371 | 6.69 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr11_72416847_72417022 | 6.66 |
Smtnl2 |
smoothelin-like 2 |
5221 |
0.14 |
chr7_67471274_67471636 | 6.65 |
Gm33926 |
predicted gene, 33926 |
27522 |
0.17 |
chr11_94917877_94918030 | 6.63 |
Gm22456 |
predicted gene, 22456 |
1756 |
0.25 |
chr3_37935136_37935311 | 6.63 |
Gm7799 |
predicted gene 7799 |
24864 |
0.14 |
chr6_148297178_148297373 | 6.57 |
Gm15763 |
predicted gene 15763 |
36125 |
0.12 |
chr8_126798037_126798188 | 6.56 |
Gm45805 |
predicted gene 45805 |
39778 |
0.15 |
chr11_116523815_116524041 | 6.55 |
Sphk1 |
sphingosine kinase 1 |
6997 |
0.1 |
chr4_127288993_127289759 | 6.51 |
Gm22221 |
predicted gene, 22221 |
4543 |
0.15 |
chr15_89020200_89020400 | 6.51 |
Mov10l1 |
Mov10 like RISC complex RNA helicase 1 |
121 |
0.91 |
chr6_138128532_138128684 | 6.50 |
Mgst1 |
microsomal glutathione S-transferase 1 |
11708 |
0.26 |
chr2_163397400_163397800 | 6.47 |
Jph2 |
junctophilin 2 |
349 |
0.83 |
chr2_174058375_174058564 | 6.46 |
Vamp7-ps |
vesicle-associated membrane protein 7, pseudogene |
11196 |
0.17 |
chr3_108759576_108759730 | 6.46 |
Aknad1 |
AKNA domain containing 1 |
561 |
0.71 |
chr4_82133017_82133195 | 6.45 |
Gm5860 |
predicted gene 5860 |
67149 |
0.11 |
chr17_26852653_26852804 | 6.45 |
Nkx2-5 |
NK2 homeobox 5 |
7719 |
0.1 |
chr9_70524366_70524816 | 6.43 |
Gm23730 |
predicted gene, 23730 |
2887 |
0.17 |
chr14_106413255_106413406 | 6.41 |
1700128A07Rik |
RIKEN cDNA 1700128A07 gene |
73162 |
0.1 |
chr16_44695981_44696180 | 6.40 |
Nepro |
nucleolus and neural progenitor protein |
28221 |
0.16 |
chr1_189619376_189619727 | 6.39 |
Gm38122 |
predicted gene, 38122 |
20683 |
0.19 |
chr15_59777517_59777937 | 6.35 |
Gm19510 |
predicted gene, 19510 |
17232 |
0.24 |
chr2_158127868_158128212 | 6.31 |
Gm20412 |
predicted gene 20412 |
10886 |
0.15 |
chr1_85502967_85503329 | 6.30 |
Gm2427 |
predicted gene 2427 |
2058 |
0.21 |
chr16_23218507_23218680 | 6.29 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
6147 |
0.11 |
chr1_78819670_78819980 | 6.25 |
Gm29187 |
predicted gene 29187 |
1433 |
0.39 |
chr9_71959727_71959977 | 6.25 |
Gm27152 |
predicted gene 27152 |
10973 |
0.11 |
chr12_79929128_79929324 | 6.23 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
3732 |
0.24 |
chr2_32514560_32514711 | 6.21 |
Gm13412 |
predicted gene 13412 |
10396 |
0.1 |
chr16_50753698_50753981 | 6.21 |
Dubr |
Dppa2 upstream binding RNA |
21066 |
0.17 |
chr19_60939895_60940340 | 6.18 |
Gm9529 |
predicted gene 9529 |
27135 |
0.14 |
chr4_57489874_57490025 | 6.18 |
Gm12539 |
predicted gene 12539 |
32400 |
0.17 |
chr5_90832541_90832696 | 6.17 |
Gm43086 |
predicted gene 43086 |
290 |
0.84 |
chr4_54712940_54713091 | 6.16 |
Gm12477 |
predicted gene 12477 |
42823 |
0.14 |
chr11_109714747_109715253 | 6.16 |
Fam20a |
family with sequence similarity 20, member A |
7256 |
0.19 |
chr10_59416732_59416883 | 6.15 |
Pla2g12b |
phospholipase A2, group XIIB |
5780 |
0.18 |
chr14_51008244_51008769 | 6.15 |
Rnase10 |
ribonuclease, RNase A family, 10 (non-active) |
577 |
0.54 |
chr4_11884927_11885135 | 6.13 |
Gm25002 |
predicted gene, 25002 |
63856 |
0.1 |
chr9_62721958_62722126 | 6.13 |
Itga11 |
integrin alpha 11 |
44182 |
0.14 |
chr13_41672989_41673200 | 6.12 |
Gm5082 |
predicted gene 5082 |
17397 |
0.19 |
chr13_49545831_49545982 | 6.10 |
Aspn |
asporin |
1419 |
0.36 |
chr5_30571971_30572122 | 6.09 |
Gm9899 |
predicted gene 9899 |
5979 |
0.14 |
chr8_88922061_88922408 | 6.09 |
Gm45504 |
predicted gene 45504 |
59160 |
0.12 |
chr5_73752381_73752532 | 6.09 |
Spata18 |
spermatogenesis associated 18 |
93195 |
0.06 |
chr17_72275407_72275698 | 6.06 |
Gm19183 |
predicted gene, 19183 |
19294 |
0.28 |
chr14_66817206_66817382 | 6.05 |
Gm9130 |
predicted gene 9130 |
18916 |
0.16 |
chr3_51268535_51268696 | 6.05 |
4930577N17Rik |
RIKEN cDNA 4930577N17 gene |
8144 |
0.12 |
chr6_30360138_30360315 | 6.04 |
Zc3hc1 |
zinc finger, C3HC type 1 |
6992 |
0.14 |
chr9_77347830_77347985 | 6.03 |
Mlip |
muscular LMNA-interacting protein |
9 |
0.97 |
chr6_97918028_97918368 | 6.03 |
Mitf |
melanogenesis associated transcription factor |
11601 |
0.24 |
chr17_49225761_49225912 | 6.02 |
Gm9586 |
predicted gene 9586 |
60078 |
0.11 |
chr6_54445544_54445719 | 6.02 |
Wipf3 |
WAS/WASL interacting protein family, member 3 |
7252 |
0.18 |
chr10_38962295_38962446 | 6.02 |
Lama4 |
laminin, alpha 4 |
3145 |
0.3 |
chr12_112490465_112491015 | 6.00 |
A530016L24Rik |
RIKEN cDNA A530016L24 gene |
1266 |
0.41 |
chr1_73259619_73259837 | 6.00 |
Gm29185 |
predicted gene 29185 |
9336 |
0.22 |
chr9_13703160_13703367 | 6.00 |
Gm47105 |
predicted gene, 47105 |
24179 |
0.16 |
chr8_126886917_126887274 | 5.99 |
Gm31718 |
predicted gene, 31718 |
10657 |
0.19 |
chr1_57437272_57437423 | 5.96 |
Gm22371 |
predicted gene, 22371 |
14974 |
0.13 |
chr4_144980888_144981094 | 5.95 |
Vps13d |
vacuolar protein sorting 13D |
2970 |
0.28 |
chrX_150845477_150846122 | 5.94 |
Gm27191 |
predicted gene 27191 |
3579 |
0.19 |
chr18_57663425_57663602 | 5.93 |
Gm26038 |
predicted gene, 26038 |
6045 |
0.19 |
chr5_123661635_123661798 | 5.93 |
Clip1 |
CAP-GLY domain containing linker protein 1 |
4974 |
0.13 |
chr11_65667485_65667686 | 5.92 |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
29429 |
0.19 |
chr9_63980393_63980740 | 5.92 |
Smad6 |
SMAD family member 6 |
36421 |
0.12 |
chr1_182986245_182986564 | 5.91 |
Gm38079 |
predicted gene, 38079 |
10128 |
0.2 |
chr7_112290032_112290391 | 5.89 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18912 |
0.26 |
chr11_95842357_95842751 | 5.89 |
Abi3 |
ABI gene family, member 3 |
78 |
0.54 |
chr1_134816609_134816962 | 5.87 |
Gm22232 |
predicted gene, 22232 |
7510 |
0.13 |
chr6_52862030_52862182 | 5.87 |
Gm15572 |
predicted gene 15572 |
18405 |
0.2 |
chr2_118717087_118717250 | 5.86 |
Plcb2 |
phospholipase C, beta 2 |
3064 |
0.17 |
chr13_3673662_3673861 | 5.85 |
Gm23084 |
predicted gene, 23084 |
25224 |
0.14 |
chr6_38624564_38624715 | 5.83 |
Klrg2 |
killer cell lectin-like receptor subfamily G, member 2 |
12594 |
0.18 |
chr6_37400778_37401412 | 5.82 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
41051 |
0.19 |
chr17_71102620_71102882 | 5.82 |
Myom1 |
myomesin 1 |
16355 |
0.15 |
chr5_35892884_35893520 | 5.81 |
Afap1 |
actin filament associated protein 1 |
117 |
0.97 |
chr4_13788116_13788304 | 5.80 |
Runx1t1 |
RUNX1 translocation partner 1 |
3428 |
0.37 |
chr16_70259483_70259667 | 5.79 |
Gm49657 |
predicted gene, 49657 |
25682 |
0.2 |
chr7_112289469_112289834 | 5.77 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18352 |
0.26 |
chr3_89214202_89214894 | 5.75 |
Mtx1 |
metaxin 1 |
118 |
0.81 |
chr11_119733134_119733291 | 5.73 |
Gm23663 |
predicted gene, 23663 |
13189 |
0.2 |
chr17_81781644_81781839 | 5.72 |
Rpl31-ps25 |
ribosomal protein L31. pseudogene 25 |
10192 |
0.26 |
chr17_12724917_12725682 | 5.68 |
Airn |
antisense Igf2r RNA |
16012 |
0.13 |
chr5_110928300_110928609 | 5.67 |
Gm15989 |
predicted gene 15989 |
23210 |
0.12 |
chr5_15575271_15575990 | 5.67 |
Gm21083 |
predicted gene, 21083 |
1703 |
0.31 |
chr5_102736197_102736419 | 5.67 |
Arhgap24 |
Rho GTPase activating protein 24 |
11335 |
0.3 |
chr14_25200807_25201012 | 5.66 |
4930572O13Rik |
RIKEN cDNA 4930572O13 gene |
57668 |
0.11 |
chr11_94882671_94882990 | 5.66 |
A430060F13Rik |
RIKEN cDNA A430060F13 gene |
21071 |
0.11 |
chr6_87271976_87272127 | 5.65 |
Antxr1 |
anthrax toxin receptor 1 |
1808 |
0.23 |
chr6_92874908_92875059 | 5.64 |
Gm15737 |
predicted gene 15737 |
5626 |
0.21 |
chr17_12723948_12724782 | 5.64 |
Airn |
antisense Igf2r RNA |
16946 |
0.13 |
chr3_144400276_144400458 | 5.63 |
Gm5857 |
predicted gene 5857 |
27305 |
0.18 |
chr12_85684508_85684678 | 5.63 |
Batf |
basic leucine zipper transcription factor, ATF-like |
2076 |
0.24 |
chr6_126966364_126966515 | 5.63 |
D6Wsu163e |
DNA segment, Chr 6, Wayne State University 163, expressed |
7981 |
0.12 |
chr13_49480140_49480315 | 5.63 |
Tes3-ps |
testis derived transcript 3, pseudogene |
13091 |
0.16 |
chr9_41877387_41877714 | 5.62 |
Gm48814 |
predicted gene, 48814 |
1231 |
0.33 |
chr18_78431142_78431531 | 5.61 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
45542 |
0.17 |
chr18_80617436_80617605 | 5.61 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
8545 |
0.19 |
chr15_99848056_99848341 | 5.60 |
Lima1 |
LIM domain and actin binding 1 |
26473 |
0.07 |
chr8_20024336_20025030 | 5.59 |
Gm45754 |
predicted gene 45754 |
5272 |
0.19 |
chr5_60042722_60043044 | 5.59 |
Gm43393 |
predicted gene 43393 |
17000 |
0.17 |
chr4_139146949_139147149 | 5.58 |
Hspe1-ps4 |
heat shock protein 1 (chaperonin 10), pseudogene 4 |
3148 |
0.18 |
chr6_30751051_30751202 | 5.56 |
Mest |
mesoderm specific transcript |
9037 |
0.13 |
chr6_94916026_94916177 | 5.55 |
4930511E03Rik |
RIKEN cDNA 4930511E03 gene |
27733 |
0.18 |
chr6_92905999_92906150 | 5.54 |
Adamts9 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 |
4633 |
0.23 |
chr4_135828546_135828880 | 5.54 |
Gm13000 |
predicted gene 13000 |
24965 |
0.1 |
chr8_19719087_19719899 | 5.53 |
Gm7760 |
predicted gene 7760 |
7788 |
0.16 |
chr14_70023117_70023268 | 5.52 |
Gm33524 |
predicted gene, 33524 |
34175 |
0.14 |
chr5_14988977_14989543 | 5.52 |
Gm10354 |
predicted gene 10354 |
10325 |
0.21 |
chr2_167713774_167713925 | 5.50 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
22668 |
0.1 |
chr2_166398944_166399580 | 5.49 |
Gm14268 |
predicted gene 14268 |
1075 |
0.58 |
chr10_116740095_116740264 | 5.49 |
4930579P08Rik |
RIKEN cDNA 4930579P08 gene |
10926 |
0.17 |
chr9_106318067_106318383 | 5.47 |
Poc1a |
POC1 centriolar protein A |
9503 |
0.13 |
chr19_32346280_32346484 | 5.47 |
Sgms1 |
sphingomyelin synthase 1 |
2934 |
0.28 |
chr1_86470446_86471284 | 5.46 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
2794 |
0.19 |
chrX_150798550_150799205 | 5.46 |
Gm24907 |
predicted gene, 24907 |
9109 |
0.16 |
chr13_53261279_53261736 | 5.45 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
14151 |
0.25 |
chr8_20817574_20818579 | 5.45 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr3_151891805_151891998 | 5.43 |
Gm43617 |
predicted gene 43617 |
4598 |
0.19 |
chr13_102577351_102577649 | 5.43 |
Gm29927 |
predicted gene, 29927 |
12785 |
0.23 |
chr5_134014322_134014518 | 5.42 |
1700030N18Rik |
RIKEN cDNA 1700030N18 gene |
77031 |
0.08 |
chr2_19703774_19703961 | 5.40 |
Gm24670 |
predicted gene, 24670 |
12579 |
0.14 |
chr6_99379027_99379368 | 5.38 |
Gm20705 |
predicted gene 20705 |
9302 |
0.24 |
chr13_56607303_56607550 | 5.38 |
Tgfbi |
transforming growth factor, beta induced |
2097 |
0.3 |
chr2_76808433_76808586 | 5.37 |
Ttn |
titin |
18033 |
0.23 |
chr13_93138172_93138334 | 5.36 |
Cmya5 |
cardiomyopathy associated 5 |
6471 |
0.19 |
chr18_38929082_38929285 | 5.36 |
Fgf1 |
fibroblast growth factor 1 |
26 |
0.98 |
chr17_48432631_48433024 | 5.35 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
103 |
0.94 |
chr1_52676671_52676851 | 5.34 |
Mfsd6 |
major facilitator superfamily domain containing 6 |
7410 |
0.15 |
chr1_82267641_82267792 | 5.33 |
Irs1 |
insulin receptor substrate 1 |
23700 |
0.16 |
chr5_118340163_118340357 | 5.32 |
Gm28563 |
predicted gene 28563 |
57070 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.9 | 8.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.4 | 7.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.2 | 6.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.1 | 8.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.6 | 7.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.5 | 7.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.4 | 4.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.4 | 4.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.3 | 5.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.2 | 5.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.2 | 3.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.2 | 2.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.2 | 4.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.2 | 4.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 4.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.1 | 3.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.1 | 3.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.1 | 5.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.0 | 3.0 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.0 | 10.9 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 3.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.0 | 2.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.9 | 2.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 2.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.9 | 1.9 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.9 | 4.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 3.6 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.9 | 2.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.9 | 0.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.9 | 5.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.9 | 1.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.9 | 2.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 2.6 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.9 | 3.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 2.5 | GO:0002434 | immune complex clearance(GO:0002434) |
0.8 | 2.5 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.8 | 3.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 0.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.8 | 4.9 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.8 | 3.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 2.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 3.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.8 | 1.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.8 | 2.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 1.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 2.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.7 | 1.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 2.9 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.7 | 3.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.7 | 2.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.7 | 2.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 3.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 3.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.7 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 4.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.7 | 3.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.0 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 2.0 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.7 | 0.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.6 | 2.6 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.6 | 0.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 2.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.6 | 2.6 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.6 | 0.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 5.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 3.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 5.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.6 | 2.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.6 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 3.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.6 | 0.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.6 | 1.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.6 | 1.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 2.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 2.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 1.7 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.6 | 2.3 | GO:0018214 | protein carboxylation(GO:0018214) |
0.6 | 2.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.6 | 1.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.6 | 1.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 1.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.6 | 2.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.6 | 1.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 3.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 1.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.6 | 1.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 1.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 4.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 3.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.5 | 2.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 2.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 2.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 2.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.5 | 1.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 1.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 1.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 0.5 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.5 | 1.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 1.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 2.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 2.0 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 1.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 2.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 1.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 1.9 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 2.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 1.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 1.0 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.5 | 0.5 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.5 | 1.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 1.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 2.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 1.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 8.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.5 | 1.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 5.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.5 | 2.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 1.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 1.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 1.4 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 4.6 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.5 | 1.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 0.5 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.5 | 1.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 0.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.4 | 1.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 0.9 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.4 | 1.8 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 3.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 0.4 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.4 | 0.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 2.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 1.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 0.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 2.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.4 | 0.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 12.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 1.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 2.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 1.3 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.4 | 1.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 5.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 0.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.4 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.4 | 3.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 0.8 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 1.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 0.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 2.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 2.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 0.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 2.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 1.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 1.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 7.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.4 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 4.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 3.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 1.2 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 0.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 0.8 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 3.5 | GO:0051923 | sulfation(GO:0051923) |
0.4 | 0.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 0.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.2 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 1.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 1.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 5.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.4 | 6.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 1.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.4 | 0.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.4 | 1.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.4 | 0.4 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.4 | 1.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 1.1 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 1.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 1.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.4 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.4 | 1.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 1.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 1.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 1.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 1.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 1.4 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 2.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 3.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 1.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.3 | 0.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 1.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.3 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.7 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.3 | 0.7 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.3 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 2.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.3 | 1.0 | GO:0003192 | mitral valve formation(GO:0003192) |
0.3 | 1.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 1.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.7 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 0.7 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.3 | 0.6 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.3 | 2.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 2.3 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.3 | 1.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 6.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 2.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 1.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 2.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 1.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 3.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 2.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 1.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 0.3 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 1.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 2.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.9 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.3 | 1.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 2.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 3.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.3 | 2.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.3 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.3 | 0.9 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 0.9 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.3 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 2.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 1.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 8.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.6 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.3 | 1.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 1.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 0.5 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 | 0.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 3.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.3 | 0.8 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 1.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.8 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 4.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 0.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 0.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 1.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 2.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 1.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 2.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 1.3 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.5 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.3 | 1.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 0.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 1.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 0.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 1.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 2.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 2.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 1.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.8 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 1.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 1.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 2.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.2 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.2 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 2.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 1.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 0.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 0.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 1.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 1.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.2 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 1.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 1.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.2 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.2 | 0.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 1.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 3.4 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 2.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.3 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.2 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.2 | 1.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.2 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.2 | 1.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 1.0 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 1.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 2.0 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.2 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 1.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 2.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.2 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.2 | 1.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 2.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.6 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.2 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.2 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.2 | 2.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.8 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 1.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 2.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 2.4 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 1.1 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 2.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.2 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.9 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.4 | GO:0072393 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.2 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.2 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.4 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.2 | 2.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.2 | 1.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.2 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 1.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.3 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.2 | 1.0 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 1.5 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.2 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 3.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 1.2 | GO:0060026 | convergent extension(GO:0060026) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.7 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 0.7 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.2 | 0.5 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.2 | 0.5 | GO:0051195 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 0.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 4.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.5 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 3.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.2 | 0.5 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.6 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 1.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 3.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 2.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.5 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 2.3 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 1.2 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.2 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.2 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 1.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 1.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 5.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 2.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.3 | GO:2000987 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.8 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.4 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 3.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 3.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.7 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.8 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.5 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.2 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 1.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.1 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.5 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.6 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 2.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.5 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 2.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.7 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 2.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.6 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 4.0 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.7 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.5 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 1.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 1.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 3.8 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 1.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.2 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.8 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.2 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 4.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.3 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 1.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.5 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 2.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.4 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.2 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 1.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 1.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.1 | 0.4 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 0.2 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.1 | 0.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0060903 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.1 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.1 | 1.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) cellular response to vitamin(GO:0071295) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 1.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.4 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.2 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 1.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.9 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.1 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.1 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.6 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 1.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.4 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 1.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 1.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 4.7 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 1.2 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.2 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 1.2 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 1.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.1 | 0.1 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0019755 | carbon dioxide transport(GO:0015670) one-carbon compound transport(GO:0019755) |
0.1 | 1.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 1.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.3 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.0 | 0.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.3 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.2 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 6.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.2 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.4 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.3 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.9 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 1.7 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.1 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.3 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.5 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.0 | GO:0034238 | macrophage fusion(GO:0034238) |
0.0 | 0.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 2.4 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.0 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 1.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
0.0 | 0.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0010743 | regulation of macrophage derived foam cell differentiation(GO:0010743) |
0.0 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.1 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 1.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.7 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.1 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.6 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.0 | 0.0 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.0 | 1.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.9 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.0 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.0 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) kidney smooth muscle tissue development(GO:0072194) |
0.0 | 0.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.0 | GO:0034205 | beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.0 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.0 | GO:0061030 | hypothalamus cell migration(GO:0021855) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.0 | 0.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.0 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.3 | 3.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.2 | 4.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 8.4 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 3.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.9 | 6.2 | GO:0071546 | pi-body(GO:0071546) |
0.9 | 7.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.9 | 2.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 5.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.8 | 3.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 2.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 1.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 3.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 2.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 2.5 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 4.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.6 | 1.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 3.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.1 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 2.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 1.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 1.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 1.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 3.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 2.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 2.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 3.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 3.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 2.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 4.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 4.0 | GO:0031430 | M band(GO:0031430) |
0.4 | 5.8 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 1.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 4.9 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.4 | 3.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 3.2 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 1.4 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 2.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.3 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 1.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 6.0 | GO:0043034 | costamere(GO:0043034) |
0.3 | 6.3 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 2.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 19.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 16.6 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 0.8 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 0.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 26.5 | GO:0030017 | sarcomere(GO:0030017) |
0.3 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 3.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 2.7 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 73.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 0.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 17.9 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.2 | 2.7 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 2.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.7 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 9.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.6 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 2.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 2.3 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 5.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 2.2 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 1.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 3.4 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 2.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.4 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 8.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.8 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 20.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 4.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 2.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 2.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 3.0 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.6 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 16.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 4.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 8.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 3.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 3.5 | GO:0005901 | caveola(GO:0005901) |
0.1 | 9.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 2.7 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.1 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 2.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.4 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 5.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 1.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 3.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 16.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.3 | 6.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.8 | 5.4 | GO:0055100 | adiponectin binding(GO:0055100) |
1.7 | 5.2 | GO:0070538 | oleic acid binding(GO:0070538) |
1.6 | 6.2 | GO:0034584 | piRNA binding(GO:0034584) |
1.4 | 4.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 5.3 | GO:0015265 | urea channel activity(GO:0015265) |
1.2 | 14.8 | GO:0044548 | S100 protein binding(GO:0044548) |
1.2 | 4.8 | GO:0031433 | telethonin binding(GO:0031433) |
1.2 | 3.6 | GO:0031014 | troponin T binding(GO:0031014) |
1.1 | 2.3 | GO:0030172 | troponin C binding(GO:0030172) |
1.1 | 3.3 | GO:0051373 | FATZ binding(GO:0051373) |
1.0 | 3.1 | GO:0048030 | disaccharide binding(GO:0048030) |
1.0 | 3.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.0 | 2.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 2.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 2.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.9 | 2.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.9 | 2.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 5.7 | GO:0018643 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.7 | 5.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 10.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.7 | 6.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 7.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 2.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 1.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 6.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 2.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 1.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 5.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 3.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 3.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 2.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 2.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 1.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 4.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.5 | 7.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 5.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 1.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 2.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 2.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 1.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.5 | 1.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 2.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.5 | 0.9 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.5 | 2.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.4 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 10.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.7 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 3.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 2.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 0.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.4 | 1.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 2.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 4.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 2.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 4.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 1.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 3.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 4.3 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 2.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 2.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 7.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 3.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 2.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 1.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 3.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 14.7 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 1.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 3.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 0.9 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 1.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 2.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 2.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 7.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 1.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 3.5 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 3.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 6.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.8 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 0.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 2.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.1 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.3 | 1.7 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 2.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 3.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 0.5 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 1.1 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 4.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 3.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 6.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 3.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.8 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 8.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 5.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 1.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 2.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 2.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 1.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 7.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.9 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 3.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 3.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.8 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 2.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 2.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 2.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 3.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 3.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.2 | 1.5 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 2.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.5 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 4.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 4.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 2.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 1.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 6.0 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 8.7 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 2.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 8.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 3.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 2.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 4.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 2.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 1.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 2.4 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 1.9 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 35.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.4 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 1.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.6 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 1.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 4.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 1.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.3 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 1.9 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 6.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.1 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 2.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.2 | GO:0018556 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.4 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.9 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 3.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 3.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 4.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.0 | 3.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.1 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.1 | GO:0004394 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 3.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 1.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 3.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.0 | 0.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.0 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 1.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 23.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 5.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 23.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 23.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 6.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 7.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 10.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 5.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 8.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 5.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 9.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 6.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 4.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 10.2 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 5.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 4.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 10.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 4.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 6.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 5.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 6.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 19.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 4.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 18.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 4.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 4.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 3.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 14.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 3.3 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 12.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 1.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.8 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.8 | 9.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.8 | 20.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 7.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 0.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.7 | 8.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 0.6 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.5 | 7.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 5.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 2.4 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.5 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 0.5 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.4 | 6.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 4.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 5.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 4.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 19.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 1.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 6.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 3.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 3.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 0.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 2.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 5.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.3 | 1.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 2.1 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 3.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 2.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 10.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 3.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 3.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 5.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 3.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 3.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 10.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 5.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 4.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 3.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 4.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 3.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 13.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 12.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 8.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 3.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 3.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 4.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 3.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 2.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 1.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 3.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |